405 related articles for article (PubMed ID: 33543649)
21. Unilateral axillary adenopathy following COVID-19 vaccination: a multimodality pictorial illustration and review of current guidelines.
Brown A; Shah S; Dluzewski S; Musaddaq B; Wagner T; Szyszko T; Wan S; Groves A; Mokbel K; Malhotra A
Clin Radiol; 2021 Aug; 76(8):553-558. PubMed ID: 34053731
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 vaccine associated axillary lymphadenopathy - A systematic review.
Co M; Wong PCP; Kwong A
Cancer Treat Res Commun; 2022; 31():100546. PubMed ID: 35334408
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram.
Raj S; Ogola G; Han J
Acad Radiol; 2022 Apr; 29(4):501-507. PubMed ID: 34906409
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT.
Lane DL; Neelapu SS; Xu G; Weaver O
Korean J Radiol; 2021 Dec; 22(12):1938-1945. PubMed ID: 34719892
[TBL] [Abstract][Full Text] [Related]
25. Axillary Lymphadenopathy in the COVID-19 Era: What the Radiologist Needs to Know.
Zhang M; Ahn RW; Hayes JC; Seiler SJ; Mootz AR; Porembka JH
Radiographics; 2022; 42(7):1897-1911. PubMed ID: 36018786
[TBL] [Abstract][Full Text] [Related]
26. Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation.
Igual-Rouilleault AC; Soriano I; Quan PL; Fernández-Montero A; Elizalde A; Pina L
Eur Radiol; 2022 May; 32(5):3199-3206. PubMed ID: 34655312
[TBL] [Abstract][Full Text] [Related]
27. Unilateral Lymphadenopathy After COVID-19 Vaccination: A Practical Management Plan for Radiologists Across Specialties.
Lehman CD; D'Alessandro HA; Mendoza DP; Succi MD; Kambadakone A; Lamb LR
J Am Coll Radiol; 2021 Jun; 18(6):843-852. PubMed ID: 33713605
[TBL] [Abstract][Full Text] [Related]
28. Imaging of COVID-19 Vaccine-Related Axillary Lymphadenopathy: Initial Outcomes Based on US Features of Axillary Lymph Nodes.
Ahn RW; Porembka JH; Mootz AR; Goudreau SH; Dogan BE; Xi Y; Seiler SJ
J Breast Imaging; 2023 Mar; 5(2):135-147. PubMed ID: 38416930
[TBL] [Abstract][Full Text] [Related]
29. US Evaluation of Axillary Lymphadenopathy Following COVID-19 Vaccination: A Prospective Longitudinal Study.
Ha SM; Chu AJ; Lee J; Kim SY; Lee SH; Yoen H; Cho N; Moon WK; Chang JM
Radiology; 2022 Oct; 305(1):46-53. PubMed ID: 35471107
[TBL] [Abstract][Full Text] [Related]
30. Frequency of Ipsilateral Axillary Lymphadenopathy After the Inactivated COVID-19 Vaccine.
Turan A; Kaplanoğlu H; Kaplanoğlu V
Curr Med Imaging; 2022; 18(11):1214-1221. PubMed ID: 35272599
[TBL] [Abstract][Full Text] [Related]
31. Adenopathy Following COVID-19 Vaccination.
Washington T; Bryan R; Clemow C
Radiology; 2021 Jun; 299(3):E280-E281. PubMed ID: 33625299
[No Abstract] [Full Text] [Related]
32. Detection of axillary lymphadenopathy after Covid-19 vaccination during breast examination: Case series and review of the literature after one year.
Veverková L; Mohelníková-Duchoňová B; Sedláčková Z; Löwová Ľ; Šišola I
Cent Eur J Public Health; 2023 Jun; 31(2):110-114. PubMed ID: 37451243
[TBL] [Abstract][Full Text] [Related]
33. COVID-19 vaccination and low cervical lymphadenopathy in the two week neck lump clinic - a follow up audit.
Mitchell OR; Couzins M; Dave R; Bekker J; Brennan PA
Br J Oral Maxillofac Surg; 2021 Jul; 59(6):720-721. PubMed ID: 33947605
[TBL] [Abstract][Full Text] [Related]
34. Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination.
Kashiwada T; Saito Y; Terasaki Y; Shirakura Y; Shinbu K; Tanaka T; Tanaka Y; Seike M; Gemma A
Hum Vaccin Immunother; 2022 Nov; 18(5):2071080. PubMed ID: 35583472
[TBL] [Abstract][Full Text] [Related]
35. Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound Features.
Cocco G; Delli Pizzi A; Taraschi AL; Boccatonda A; Corvino A; Ucciferri C; Falasca K; Caulo M; Vecchiet J
Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208521
[No Abstract] [Full Text] [Related]
36. Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients throughout COVID-19 Vaccination Era.
Giordano A; Gallicchio R; Milella M; Storto R; Nardelli A; Pellegrino T; Nappi A; Di Cosola M; Storto G
Curr Pharm Des; 2024; 30(10):798-806. PubMed ID: 38454762
[TBL] [Abstract][Full Text] [Related]
37. Axillary lymph nodes enlargement after Sars-CoV-2 vaccine in patients undergoing breast examination: comment.
Kleebayoon A; Wiwanitkit V
Radiol Med; 2023 Dec; 128(12):1593-1594. PubMed ID: 37962776
[No Abstract] [Full Text] [Related]
38. Unilateral axillary Adenopathy in the setting of COVID-19 vaccine.
Mehta N; Sales RM; Babagbemi K; Levy AD; McGrath AL; Drotman M; Dodelzon K
Clin Imaging; 2021 Jul; 75():12-15. PubMed ID: 33486146
[TBL] [Abstract][Full Text] [Related]
39. COVID-19 vaccination and breast cancer surgery timing.
Ko G; Hota S; Cil TD
Breast Cancer Res Treat; 2021 Aug; 188(3):825-826. PubMed ID: 34156582
[TBL] [Abstract][Full Text] [Related]
40. COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature.
Lim J; Lee SA; Khil EK; Byeon SJ; Kang HJ; Choi JA
Semin Oncol; 2021; 48(4-6):283-291. PubMed ID: 34836672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
